The Utility of 18F-FDG PET/CT in Detecting Multiple Metastases in Papillary Renal Cell Carcinoma

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Molecular Imaging and Radionuclide Therapy Pub Date : 2024-07-17 DOI:10.4274/mirt.galenos.2024.02259

Melis Oflas, Duygu Has Şimşek, S. Kuyumcu, Murat Yılmaz Kıran, Y. Şanlı

引用次数: 0

Abstract

The diagnostic performance of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) for primary kidney tumors is limited. Nevertheless, 18 F-FDG PET/CT is valuable for staging renal cell carcinoma (RCC) when suspected metastases coexist, as one-third of patients with RCC have distant metastases upon diagnosis. Herein, we present a 53-year-old male patient with extensive 18 F-FDG-avid metastatic lesions and an 18 F-FDG-avid renal mass, which later revealed RCC

查看原文本刊更多论文

18F-FDG PET/CT 在检测乳头状肾细胞癌多处转移中的实用性

18 F-氟脱氧葡萄糖（18 F-FDG）正电子发射断层扫描/计算机断层扫描（PET/CT）对原发性肾肿瘤的诊断效果有限。尽管如此，18 F-FDG 正电子发射断层扫描/计算机断层扫描（PET/CT）在肾细胞癌（RCC）疑似转移灶并存时仍有分期价值，因为三分之一的 RCC 患者在确诊时已有远处转移。在此，我们介绍了一位 53 岁的男性患者，他患有广泛的 18 F-FDG 亲和转移灶和 18 F-FDG 亲和肾肿块，后来发现了 RCC

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Imaging and Radionuclide Therapy RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.